Bank of Nova Scotia’s bluebird bio BLUE Stock Holding History

Bank of Nova Scotia’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,064	Closed	-$511K	–	1205
2021 Q3	$511K	Buy	+2,064	New	+$590K	﹤0.01%	996

Other funds holding BLUE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Nova Scotia's BLUE Position: Q4 2021 in Review

Bank of Nova Scotia sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 2,064 shares — an estimated $511K sold.

Bank of Nova Scotia first reported a position in BLUE in Q3 2021 and held it in 1 quarter. The position peaked at $511K in Q3 2021. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

Bank of Nova Scotia reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
Bank of Nova Scotia sold 2,064 bluebird bio shares in Q4 2021, an estimated $511K.
Bank of Nova Scotia first reported a position in bluebird bio in Q3 2021 and held it in 1 quarter.
Bank of Nova Scotia's bluebird bio position peaked at $511K in Q3 2021.
172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Bank of Nova Scotia's 13F filing for Q4 2021, filed 11 Feb 2022.